NORTH
CHICAGO, Ill., March 4,
2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) will
participate at the Leerink Partners Global Healthcare Conference on
Tuesday, March 11, 2025. Management
will participate in a fireside chat at 7:40
a.m. Central time.
A live audio webcast of the presentation will be accessible
through AbbVie's Investor Relations website at
investors.abbvie.com. An archived edition of the session will be
available later that day.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
and solutions that solve serious health issues today and address
the medical challenges of tomorrow. We strive to have a remarkable
impact on people's lives across several key therapeutic areas –
immunology, oncology, neuroscience, and eye care – and products and
services in our Allergan Aesthetics portfolio. For more information
about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on
LinkedIn, Facebook, Instagram, X (formerly Twitter), and
YouTube.
|
Media:
|
Investors:
|
|
Gabby
Tarbert
|
Liz Shea
|
|
(224)
244-0111
|
(847) 935-2211
|
|
gabrielle.tarbert@abbvie.com
|
liz.shea@abbvie.com
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-leerink-partners-global-healthcare-conference-302390547.html
SOURCE AbbVie
